The PATCH trial: 5% lidocaine-medicated plaster for trigeminal neuralgia-Results of a multicentric, enriched enrollment, randomized withdrawal, double-blind, vehicle-controlled, parallel-group study.
Chunmei ZhaoNiti ShresthaHao RenBaohui ZhangYing ShenLan MengDasheng WuBaoguo WangBifa FanFang LuoPublished in: Headache (2024)
LMP produced partial relief of pain symptoms in some patients with TN. For responders, LMP may be used as an add-on therapy in a multidrug treatment protocol.
Keyphrases
- double blind
- phase iii
- placebo controlled
- phase ii
- epstein barr virus
- clinical trial
- open label
- study protocol
- neuropathic pain
- chronic pain
- randomized controlled trial
- pain management
- drug resistant
- healthcare
- stem cells
- health insurance
- spinal cord injury
- combination therapy
- multidrug resistant
- mesenchymal stem cells
- smoking cessation
- depressive symptoms